Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javad Fattahi

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 21, 2025
Heterogeneity in benign and malignant salivary gland tumorsMehdi Ghasemian, Mohammad Amin Gholami, Mohammad Javad Fattahi, et al.
Pathology Oncology Research : POR|March 27, 2010
Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progressionZahra Mojtahedi, Bijan Khademi, Seyed Basir Hashemi, et al.
Inflammopharmacology|October 25, 2017
Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritisHossein Ahmadi, Mahdi Mahmoudi, Farhad Gharibdoost, et al.
Iranian Journal of Allergy, Asthma, and Immunology|November 19, 2017
Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive PropertyHossein Ahmadi, Ahmad Reza Jamshidi, Mahdi Mahmoudi, et al.
Turkish Journal of Obstetrics and Gynecology|June 10, 2024
Investigation of <i>PD-1</i> gene variants in patients with endometrial cancer: A case-control studyMohammad Javad Fattahi, Mozhdeh Momtahan, Maryam Poostkar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 4, 2012
HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevatedYasaman Sardari, Soheil Pardis, Azadeh Andisheh Tadbir, et al.
Iranian Journal of Otorhinolaryngology|December 5, 2013
Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell CarcinomaSoheil Pardis, Yasaman Sardari, Mohammad Javad Ashraf, et al.
Viral Immunology|August 11, 2023
Investigation of the Seroprevalence of Antimeasles Immunoglobulin G Antibody in Students at Shiraz University of Medical SciencesMohammad Kia, Fatemeh Nekooei, Amir Hossein Alipour, et al.
Scientific Reports|April 14, 2025
Role of serum IL-35 levels in patients with benign and malignant primary ovarian tumors: a case-control studyLeila Kiani, Mozhdeh Momtahan, Zahra Shiravani, et al.
Current Drug Discovery Technologies|March 23, 2017
The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid ArthritisHossein Ahmadi, Ahmad R Jamshidi, Mahdi Mahmoudi, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 21, 2025
Heterogeneity in benign and malignant salivary gland tumorsMehdi Ghasemian, Mohammad Amin Gholami, Mohammad Javad Fattahi, et al.
Pathology Oncology Research : POR|March 27, 2010
Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progressionZahra Mojtahedi, Bijan Khademi, Seyed Basir Hashemi, et al.
Inflammopharmacology|October 25, 2017
Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritisHossein Ahmadi, Mahdi Mahmoudi, Farhad Gharibdoost, et al.
Iranian Journal of Allergy, Asthma, and Immunology|November 19, 2017
Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive PropertyHossein Ahmadi, Ahmad Reza Jamshidi, Mahdi Mahmoudi, et al.
Turkish Journal of Obstetrics and Gynecology|June 10, 2024
Investigation of <i>PD-1</i> gene variants in patients with endometrial cancer: A case-control studyMohammad Javad Fattahi, Mozhdeh Momtahan, Maryam Poostkar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 4, 2012
HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevatedYasaman Sardari, Soheil Pardis, Azadeh Andisheh Tadbir, et al.
Iranian Journal of Otorhinolaryngology|December 5, 2013
Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell CarcinomaSoheil Pardis, Yasaman Sardari, Mohammad Javad Ashraf, et al.
Viral Immunology|August 11, 2023
Investigation of the Seroprevalence of Antimeasles Immunoglobulin G Antibody in Students at Shiraz University of Medical SciencesMohammad Kia, Fatemeh Nekooei, Amir Hossein Alipour, et al.
Scientific Reports|April 14, 2025
Role of serum IL-35 levels in patients with benign and malignant primary ovarian tumors: a case-control studyLeila Kiani, Mozhdeh Momtahan, Zahra Shiravani, et al.
Current Drug Discovery Technologies|March 23, 2017
The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid ArthritisHossein Ahmadi, Ahmad R Jamshidi, Mahdi Mahmoudi, et al.
Pageof 6